[NEU] YoY Quarter Result on 30-Jun-2023 [#Q2]

Stock
[NEU] Neuren Pharmaceuticals Limited
Announcement Date
29-Jun-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- 560.47%
YoY- 777.70%
Quarter Report
NEU's Result
NEU's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 24,327 62,926 0 0 0 0 0 -
PBT 11,843 49,622 -7,054 -7,964 -4,761 -7,885 -4,096 -
Tax 3,827 1,817 0 0 0 0 0 -
NP 8,016 47,805 -7,054 -7,964 -4,761 -7,885 -4,096 -
Tax Rate -32.31% -3.66% - - - - - -
Total Cost 16,311 15,121 7,054 7,964 4,761 7,885 4,096 25.87%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin 32.95 75.97 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS 0.06 0.38 -0.06 -0.07 -0.05 -0.08 -0.04 -
EPS Diluted 0.06 0.37 -0.06 -0.07 -0.05 -0.08 -0.04 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.